RANI Insider Trading Activity and SEC Form 4 Filings
RANI insider trading summary
Over the past 12 months, insiders at Rani Therapeutics Holdings, Inc. (RANI) reported 2 open-market purchases worth $50K by 2 insiders and 1 sale worth $301 by 1 insider on SEC Form 4. Net insider buying was $50K.
Latest RANI insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jul 21, 2026 | Mir A Imran | Insider | Buy | $25K (36,000 @ $0.69) |
| Jul 17, 2026 | Talat Imran | Chief Executive Officer | Buy | $25K (35,000 @ $0.72) |
| Mar 27, 2026 | Alireza Javadi | Chief Technical Officer | Sell | $301 (386 @ $0.78) |
| Oct 23, 2025 | Mir A Imran | Insider | Buy | $1.3M (2,083,334 @ $0.60) |
| Oct 21, 2025 | South Cone Investments Limited Partnership | 10% Owner | Sell | $11.1M (4,000,000 @ $2.77) |
| Oct 20, 2025 | South Cone Investments Limited Partnership | 10% Owner | Sell | $4.6M (1,923,000 @ $2.41) |
| Dec 27, 2024 | Talat Imran | Chief Executive Officer | Sell | $11K (8,014 @ $1.41) |
| Dec 13, 2024 | Kate McKinley | Chief Business Officer | Buy | $30K (17,960 @ $1.67) |
| Dec 9, 2024 | Talat Imran | Chief Executive Officer | Buy | $20K (10,296 @ $1.94) |
| Oct 15, 2024 | South Lake One LLC | 10% Owner | Sell | $1.7M (523,738 @ $3.26) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.